169 related articles for article (PubMed ID: 8053196)
1. [Chronic lymphatic leukemia].
Lechner K; Bilbeisi S; Wittmann E; Wilfing A
Wien Klin Wochenschr; 1994; 106(10):291-9. PubMed ID: 8053196
[TBL] [Abstract][Full Text] [Related]
2. Management of chronic lymphocytic leukemia.
Han T; Rai KR
Hematol Oncol Clin North Am; 1990 Apr; 4(2):431-45. PubMed ID: 2182600
[TBL] [Abstract][Full Text] [Related]
3. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
5. [Advances in the treatment of chronic lymphocytic leukemia (CLL)].
Lechner K; Jäger U; Geissler K; Greinix H; Kalhs P
Wien Klin Wochenschr; 1998 Oct; 110(20):701-8. PubMed ID: 9857427
[TBL] [Abstract][Full Text] [Related]
6. Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
Pavletic ZS; Arrowsmith ER; Bierman PJ; Goodman SA; Vose JM; Tarantolo SR; Stein RS; Bociek G; Greer JP; Wu CD; Kollath JP; Weisenburger DD; Kessinger A; Wolff SN; Armitage JO; Bishop MR
Bone Marrow Transplant; 2000 Apr; 25(7):717-22. PubMed ID: 10745256
[TBL] [Abstract][Full Text] [Related]
7. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
Abbott BL
Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
[TBL] [Abstract][Full Text] [Related]
8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
10. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
11. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
12. [Chronic lymphatic leukemia].
Hinterberger W
Wien Med Wochenschr; 1991; 141(9-10):198-201. PubMed ID: 1949842
[TBL] [Abstract][Full Text] [Related]
13. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
14. Treatment of B-cell chronic lymphocytic leukaemia: current status and future perspectives.
Montserrat E; Bosch F; Rozman C
J Intern Med Suppl; 1997; 740():63-7. PubMed ID: 9350185
[TBL] [Abstract][Full Text] [Related]
15. Recent progress in the management of chronic lymphocytic leukemia.
Robak T
Cancer Treat Rev; 2007 Dec; 33(8):710-28. PubMed ID: 17904294
[TBL] [Abstract][Full Text] [Related]
16. Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.
O'Brien S; Moore JO; Boyd TE; Larratt LM; Skotnicki A; Koziner B; Chanan-Khan AA; Seymour JF; Bociek RG; Pavletic S; Rai KR
J Clin Oncol; 2007 Mar; 25(9):1114-20. PubMed ID: 17296974
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.
Toze CL; Shepherd JD; Connors JM; Voss NJ; Gascoyne RD; Hogge DE; Klingemann HG; Nantel SH; Nevill TJ; Phillips GL; Reece DE; Sutherland HJ; Barnett MJ
Bone Marrow Transplant; 2000 Mar; 25(6):605-12. PubMed ID: 10734294
[TBL] [Abstract][Full Text] [Related]
18. First-line therapy of advanced chronic lymphocytic leukemia.
Wilhelm M; Tony HP; Rueckle-Lanz H; Wilms K
Leukemia; 1997 Apr; 11 Suppl 2():S14-8. PubMed ID: 9178832
[TBL] [Abstract][Full Text] [Related]
19. Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission.
Oudat R; Keating MJ; Lerner S; O'Brien S; Albitar M
Leukemia; 2002 Apr; 16(4):632-5. PubMed ID: 11960343
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
